Navigation Links
Clarient to Commercialize Novel Breast Cancer Profile
Date:1/9/2008

sts, the potential market for breast cancer tests that identify recurrence risk is estimated to be between $300 million and $400 million annually in the U.S.

The new breast cancer profile, the most significant test to date in Clarient's novel marker program, is the first product in Clarient's Insight Dx line of molecular tests. These tests are being commercialized to provide valuable cancer characterization information for prognosis and therapy selection for the major cancer types.

"This new agreement provides Clarient with an important addition to our breast cancer menu -- a new molecular diagnostic test that we believe predicts the likelihood of disease recurrence, and ultimately the benefit of chemotherapy for patients," said Clarient's President and CEO Ron Andrews. "Along with its significant value for the over 35,000 breast cancer patients we expect to test this year, Clarient's Insight Dx Breast Cancer Profile has the potential to deliver a significant economic opportunity for the company."

"We are excited to have entered into this agreement with Clarient," said Cornelius Diamond, Chief Executive Officer of Prediction Sciences. "The Clarient Insight Dx Breast Cancer Profile is the first in a pipeline of tests developed by Prediction Sciences that we believe will significantly improve and personalize patient care. We believe that Clarient is well positioned to commercialize this test and provide invaluable benefit to breast cancer patients and their physicians, allowing them to make informed treatment decisions."

Andrews added that the Clarient Insight Dx Breast Cancer Profile is the first of its kind to combine proteomic and genomic markers with tumor morphology data received directly from the patient's pathologist, thereby allowing a more accurate characterization of the disease.

"This clearly fits our business model of engaging and empowering the community pathologist in the analysis process," Andrews said. "We believe tha
'/>"/>

SOURCE Clarient
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
3. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
4. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
5. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
6. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
7. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
8. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
9. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
10. First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
11. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... RegeneCure announced today the ... Guided Bone Regeneration (GBR) Dental Membrane as a bone stimulating ... problem encountered when patients have a tooth replaced with a ... house the implant. Consequently there is often a need to ... bone regenerates. The bone substitute material, in turn, needs to ...
(Date:6/18/2013)...  AMRI (NASDAQ: AMRI ) announced ... , site has received approval to expand its ... handle Schedule 2 and 2N controlled substances. The ... Burlington,s physical security and quality systems, ... http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With its ...
(Date:6/18/2013)... 18, 2013 This webinar will ... advertising and promotion, and review the basic FDA ... how to apply these principles through real world ... ,     The fundamentals on FDA regulations and guidance ... ,     Assessing traditional and newer forms of ...
(Date:6/18/2013)... 2013 As a leading provider ... announces the release of their infographic - " ... , MeMD's goal was to leverage an information ... 2.0, Health 3.0 and mHealth.The infographic features a ... care and the fitness industry in unimaginable ways; ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
... of the mad cow scare in Great Britain, the parody ... for Irish consumption. The headline was good for a laugh ... how choices were made during the 1996 British outbreak. , ... the British scare were made by politicians and business people, ...
... , ,Lets start with the good in Midwest biotech in ... publicly traded Midwest biotech companies as measured by the ePrairie ... of the region. , ,Last week, I commented on ... which grew 45 percent last year and actually ticked up ...
... of Fiserv, Inc. has announced the launch ... self-funded health care market. , , Fiserv Health ... administration services for self-funded medical, dental, vision and disability ... now has an integrated suite of medical management programs ...
Cached Biology Technology:Lets Use Science to Corral Mad Cow Disease and the Public Stampede 2Lets Use Science to Corral Mad Cow Disease and the Public Stampede 3The Good, Bad, Ugly of Midwest Biotech in 2003 2The Good, Bad, Ugly of Midwest Biotech in 2003 3Fiserv Launches Avidyn Health to Target Healthcare Costs 2
(Date:6/18/2013)... Ph.D., Medical Research Council, Laboratory of Molecular Biology, ... 2013 ICAAC Young Investigator Award. Torrent is being ... the first algorithm to predict antimicrobial regions in ... "we are now applying this algorithm to interrogate ... peptide leads with very appealing results." , ...
(Date:6/18/2013)... 2013: The Association for Molecular Pathology is proud to ... for Experimental Biology (FASEB) on July 1, 2013. The ... 3, 2013. , The 26 constituent societies of ... common vision for the advancement of research and education ... research is more important now than ever," said Jennifer ...
(Date:6/18/2013)... Methylation refers to a chemical modification of DNA ... positions in the DNA sequence. Until now, scientists ... expression of certain genes. Today, a team of ... led by Emmanouil Dermitzakis, Louis-Jeantet Professor at the ... always the case and that DNA methylation may ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2The secret of DNA methylation 2
... Massachusetts, December 14, 2011 The Concord Consortium ( ... Google.org to pave the way for digital curricula that ... is finally arriving for education, but most examples out ... can offer. We,re hard at work creating better, deeply ...
... in new flame-retardant products are showing up in ... recent study by researchers at Indiana University Bloomington. ... Science & Technology, reports on concentrations of two ... Great Lakes region between 2008 and 2010. Authors ...
... GALVESTON, Dec. 13, 2011 Stillbirth is associated ... before or at the start of pregnancy, including prior ... diabetes, obesity and smoking. These findings are the result ... in the December 14th issue of the Journal ...
Cached Biology News:The Concord Consortium awarded multi-million dollar Google grant 2Study finds increasing atmospheric concentrations of new flame retardants 2Risk of stillbirth associated with factors known early in pregnancy 2
...
...
Request Info...
... IS System is ideal for developing single ... This system contains the new, improved, and ... The user can design specific templates for ... has fully integrated graphing and data regression ...
Biology Products: